LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahendrabhai Gulabdas Patel LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahendrabhai Gulabdas Patel Lincoln Pharmaceuticals acquires Cephalosporin plant in Mehsana
Lines up 20 Cephalosporin antibiotic products for launch Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed a Press Release titled 'Lincoln Pharmaceuticals Ltd plans to launch Cephalosporin products soon: acquires a plant in Mehsana, Gujarat.' NCLT nod for amalgamation of Lincoln Parenteral and Lincoln Pharmaceuticals
It is expected to bring synergies in terms of operations efficiency, enhance competitive strength, the company said LINCOLN PHARMACEUTICALS LTD. - 531633 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to the above captioned subject, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed a Press Release titled 'National Company Law Tribunal approves scheme of amalgamation of Lincoln Parenteral Ltd and Lincoln Pharmaceuticals Ltd'. Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Hon''ble National Company Law Tribunal, Ahmedabad Bench, (''NCLT'') has sanctioned the scheme of Amalgamation of Lincoln Parenteral Limited ('Transferor Company') and Lincoln Pharmaceuticals Limited ('Transferee Company') and their respective shareholders and creditors vide its order dated September 14, 2021 and has been uploaded on the website of Hon''ble NCLT on September 15, 2021. The copy of order is attached as annexure to this letter. Appointed date of the Scheme is April 01, 2019. The Scheme will be effective upon filing of certified copy of the order of the Hon''ble NCLT with the Registrar of Companies, Gujarat. LINCOLN PHARMACEUTICALS LTD. - 531633 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel LINCOLN PHARMACEUTICALS LTD. - 531633 - Newspaper Publication For Notice Of 27Th Annual General Meeting
Pursuant to Regulation 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the copies of published newspaper advertisement with respect to the Notice of 27th Annual General Meeting of the Company scheduled to be held on Thursday, September 30, 2021 at 11:00 a.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM), Book Closure and E-Voting instructions, published in the following newspapers: 1. The Indian Express, Ahmedabad Edition - In English; 2. Financial Express, Ahmedabad Edition - In Gujarati (Vernacular). LINCOLN PHARMACEUTICALS LTD. - 531633 - Reg. 34 (1) Annual Report
Pursuant to Regulation 34 (1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the SEBI Listing Regulations'), we are submitting herewith the Annual Report of the Company along with the Notice of Twenty Seven Annual General Meeting ('AGM') for the Financial Year 2020-2021.